Lamictal Related Published Studies
Well-designed clinical trials related to Lamictal (Lamotrigine)
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. [2008.06.15]
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. [2008.05.27]
Population pharmacokinetics of lamotrigine in elderly patients. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
[A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study] [2008.02.16]
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. [2008.01.01]
Open-label, concomitant use of lamotrigine and other medications for bipolar disorder. [2008.01]
Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study. [2008]
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. [2007.12.12]
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. [2007.12]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. [2007.10]
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. [2007.09]
Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain. [2007.07.25]
Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy. [2007.07.25]
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. [2007.07]
The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study. [2007.07]
Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. [2007.07]
Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder. [2007.05.22]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: A double-blind, placebo-controlled study. [2007.03.23]
Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. [2007.03]
Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. [2007.03]
Lamotrigine in patients with epilepsy and comorbid depressive symptoms. [2007.02]
Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy. [2006.09]
Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases. [2006.09]
Adjunctive treatment for mood stabilization of patients with bipolar I disorder treated with lamotrigine. [2006.09]
Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. [2006.08.08]
Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects. [2006.08]
Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. [2006.08]
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. [2006.07]
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. [2006.07]
Effect of lamotrigine on cognition in children with epilepsy. [2006.05.23]
Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate. [2006.04]
Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects. [2006.04]
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. [2006.04]
The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial. [2006.03]
Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity. [2006.03]
A single-center, double-blind, placebo-controlled evaluation of lamotrigine in the treatment of obesity in adults. [2006.02]
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. [2006.02]
Subjective preference for lamotrigine or topiramate in healthy volunteers: Relationship to cognitive and behavioral functioning. [2006.02]
Lamotrigine versus carbamazepine monotherapy for epilepsy. [2006.01.25]
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. [2005.12.13]
Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine. [2005.12]
The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. [2005.12]
Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity. [2005.11.19]
Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. [2005.06.28]
New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. [2005.06.14]
Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. [2005.05]
A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. [2005.03]
In vivo biopharmaceutical characterisation of a new formulation containing the antiepileptic drug lamotrigine in comparison to plain and dispersible/chewable lamotrigine tablets. [2005]
Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: a randomized, controlled study. [2005]
Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia. [2004.09.15]
Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. [2004.09]
Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. [2004.08]
Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. [2004.07]
Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model. [2004.06]
Quality of life improvement with conversion to lamotrigine monotherapy. [2004.04]
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. [2004.03]
A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. [2004.02]
Long-term tolerability of lamotrigine: data from a 6-year continuation study. [2004.02]
Modulation of neuroendocrine response and non-verbal behavior during psychosocial stress in healthy volunteers by the glutamate release-inhibiting drug lamotrigine. [2004.01]
Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial. [2003.12.01]
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. [2003.12]
Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. [2003.12]
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. [2003.09]
A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. [2003.09]
Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. [2003.09]
A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters. [2003.07]
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. [2003.05.13]
A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. [2003.04]
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. [2003.04]
A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. [2003.03]
Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial. [2003.02]
Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. [2002.09]
Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. [2002.09]
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin. [2002.05]
Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. [2002.04]
Lamotrigine in spinal cord injury pain: a randomized controlled trial. [2002.04]
Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. [2002.02.01]
Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. [2002.01]
Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. [2001.08.14]
A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. [2001.08]
Differential cognitive and behavioral effects of carbamazepine and lamotrigine. [2001.05.08]
Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. [2001.04]
A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy. [2001.03]
Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally. [2001.02]
Lamotrigine for central poststroke pain: a randomized controlled trial. [2001.01.23]
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. [2001.01.23]
Lamotrigine add-on for drug-resistant partial epilepsy. [2001]
An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. [2000.12]
Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects. [2000.12]
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. [2000.12]
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. [2000.11]
Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine. [2000.11]
A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. [2000.09]
The effects of lamotrigine on the pharmacokinetics of lithium. [2000.09]
Lamotrigine improves cerebral outcome after hypothermic circulatory arrest: a study in a chronic porcine model. [2000.08]
Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects. [2000.07]
Rectal absorption of lamotrigine compressed tablets. [2000.07]
A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. [2000.06.13]
|
